# Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

> **NCT05079607** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 112 (actual)

## Conditions studied

- Irritation/Irritant
- Sensitisation

## Interventions

- **OTHER:** Mitopure Topical Formula 1
- **OTHER:** Mitopure Topical Formula 2

## Key facts

- **NCT ID:** NCT05079607
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-04
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2021-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079607, "Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05079607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*